NIVOROZHKIN; Alex

Patent Applications and Registrations

Patent applications and USPTO patent grants for NIVOROZHKIN; Alex.The latest application filed is for "deuterated tryptamine derivatives and methods of use".

Company Profile

11.19.29

NIVOROZHKIN; Alex - West Roxbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Deuterated Tryptamine Derivatives And Methods Of Use App 20220119346 - NIVOROZHKIN; Alex ; et al.	2022-04-21
Neuro-attenuating Ketamine And Norketamine Compounds, Derivatives Thereof, And Methods App 20220106258 - Nivorozhkin; Alex ; et al.	2022-04-07
Deuterated tryptamine derivatives and methods of use Grant 11,242,318 - Nivorozhkin , et al. February 8, 2	2022-02-08
Methods And Related Tools For Cbd Conversion To Thc App 20210363125 - Nivorozhkin; Alex	2021-11-25
Deuterated Tryptamine Derivatives And Methods Of Use App 20210363104 - NIVOROZHKIN; Alex ; et al.	2021-11-25
Methods and related tools for CBD conversion to THC Grant 11,098,024 - Nivorozhkin August 24, 2	2021-08-24
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Grant 10,981,859 - Nivorozhkin , et al. April 20, 2	2021-04-20
Single-layer Oral Dose Of Neuro-attenuating Ketamine App 20200261370 - Nivorozhkin; Alex ; et al.	2020-08-20
Novel Methods And Related Tools For Cbd Conversion To Thc App 20200223814 - Nivorozhkin; Alex	2020-07-16
Single layer oral dose of neuro-attenuating ketamine Grant 10,653,629 - Nivorozhkin , et al.	2020-05-19
Neuro-attenuating Ketamine And Norketamine Compounds, Derivatives Thereof, And Methods App 20190263749 - Nivorozhkin; Alex ; et al.	2019-08-29
System And Method For Detection Of A Contaminated Beverage App 20190250137 - Abramson; Michael T. ; et al.	2019-08-15
System and method for detection of a contaminated beverage Grant 10,274,475 - Abramson , et al.	2019-04-30
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Grant 10,252,982 - Nivorozhkin , et al.	2019-04-09
Single-layer Oral Dose Of Neuro-attenuating Ketamine App 20180153813 - Nivorozhkin; Alex ; et al.	2018-06-07
System and method for detection of a contaminated beverage Grant 9,989,509 - Abramson , et al. June 5, 2	2018-06-05
Degradation resistant HSP70 formulations and uses thereof Grant 9,937,241 - Onikienko , et al. April 10, 2	2018-04-10
Single-layer oral dose of neuro-attenuating ketamine Grant 9,913,803 - Nivorozhkin , et al. March 13, 2	2018-03-13
Neuro-attenuating Ketamine And Norketamine Compounds, Derivatives Thereof, And Methods App 20170355663 - Nivorozhkin; Alex ; et al.	2017-12-14
System And Method For Detection Of A Contaminated Beverage App 20170160253 - ABRAMSON; MICHAEL T. ; et al.	2017-06-08
Methods of use of HSP70 for increased performance or treatment of HSP70 related disorders Grant 9,616,100 - Onikienko , et al. April 11, 2	2017-04-11
Single-layer Oral Dose Of Neuro-attenuating Ketamine App 20160199304 - Nivorozhkin; Alex ; et al.	2016-07-14
System And Method For Detection Of A Contaminated Beverage App 20160146773 - Abramson; Michael T. ; et al.	2016-05-26
System and method for detection of a contaminated beverage Grant 9,285,352 - Abramson , et al. March 15, 2	2016-03-15
HSP70 fusion protein conjugates and uses thereof Grant 9,217,018 - Onikienko , et al. December 22, 2	2015-12-22
System And Method For Detection Of A Contaminated Beverage App 20150104861 - Abramson; Michael T. ; et al.	2015-04-16
Novel Methods Of Use Of Hsp70 For Increased Performance Or Treatment Of Hsp70 Related Disorders App 20140329764 - Onikienko; Sergei B. ; et al.	2014-11-06
Hsp70 Fusion Protein Conjugates And Uses Thereof App 20130156694 - Onikienko; Sergei B. ; et al.	2013-06-20
Degradation Resistant Hsp70 Formulations And Uses Thereof App 20130101573 - Onikienko; Sergei B. ; et al.	2013-04-25
Novel Methods Of Use Of Hsp70 For Increased Performance Or Treatment Of Hsp70 Related Disorders App 20130090294 - Onikienko; Sergei B. ; et al.	2013-04-11
Parenteral Formulations Of Dopamine Agonists App 20100035886 - Cincotta; Anthony H. ; et al.	2010-02-11
5-Aryltetrazole compounds and uses thereof Grant 7,135,491 - Nivorozhkin , et al. November 14, 2	2006-11-14
Aryltetrazole compounds, and compositions thereof Grant 7,087,631 - Nivorozhkin , et al. August 8, 2	2006-08-08
5-Aryltetrazole compounds, compositions thereof, and uses therefor Grant 7,078,423 - Nivorozhkin , et al. July 18, 2	2006-07-18
5-Aryltetrazoles compounds and compositions thereof App 20050159418 - Nivorozhkin, Alex ; et al.	2005-07-21
5-Aryltetrazole compounds and uses thereof App 20050159467 - Nivorozhkin, Alex ; et al.	2005-07-21
5-Aryltetrazole compounds, compositions thereof, and uses therefor App 20040116423 - Nivorozhkin, Alex ; et al.	2004-06-17
5-Aryltetrazole Compounds, compositions thereof, and uses therefor App 20040019208 - Nivorozhkin, Alex ; et al.	2004-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.